三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
我国主要百白破类疫苗产品
我国主要百白破类疫苗产品
其它
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:108KB
图片尺寸:1866*422
同报告图片
/
4
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
所属报告:
百克生物-公司研究报告-百战克疫稳增长带疱疫苗再争锋-231231(37页).pdf
打包全文图表
相关数据
图表40目前我国已上市的主要百白破类疫苗产品
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
收藏
行业数据
2021-12-27
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
组分百白破疫苗可控性、安全性及免疫效果更好,国内市场尚空白。除赛诺菲的五联苗外,国内生产上市产品均为无细胞共纯化百白破疫苗,尚无组分百白破疫苗。公司正在研发的是吸附无细胞百白破(三组分)联合疫苗,组分百白破疫苗由经单一纯化的百日咳杆菌抗原组分原液(包括百日咳类毒素、丝状血凝素及 69KD外膜蛋白)和白喉类毒素原液、破伤风类毒素原液分别经氢氧化铝佐剂吸附后,按比例混合制成。较共纯化百白破疫苗,组分百白破联合疫苗的成分可控性更高,据《J PHARMACEUT BIOMED》,一般情况下组分百白破疫苗内百日咳毒素、丝状血凝素和粘附素等抗原蛋白含量相对共纯化百白破疫苗更高;共纯化百白破疫苗抗原组分及组成比例不确定,造成批次间效价不稳定,质量可控性较差。此外,《FRONTIERS IN IMMUNOLOGY》的数据显示,在 96个月内,注射组分百白破疫苗个体的各类相关抗体水平均显著高于注射共纯化百白破疫苗个体,说明组分百白破疫苗的免疫效果更好。
其它
原图定位
当前图表所属:
百克生物-公司研究报告-百战克疫稳增长带疱疫苗再争锋-231231(37页).pdf
公司带状疱疹减毒活疫苗Ⅱ期临床试验不良反应情况
北京市东城区303名Shingrix受试者不良反应情况
公司带状疱疹疫苗部分地区首针接种情况
带状疱疹疫苗市场空间测算(亿元)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》